Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs

https://themarketherald.com.au/botanix-pharmaceuticals-asxbot-launches-phase-2-btx-1801-study-for-ssis-2020-03-13

Botanix Pharmaceuticals plans new study into antimicrobial platform and BTX 1801

https://smallcaps.com.au/botanix-pharmaceuticals-plans-new-study-antimicrobial-platform-btx-1801